Fundraising Fox
Sensus Healthcare
NASDAQ: SRTSBoca Raton, US · Delaware corporation
Find your way into Sensus Healthcare
270 people in our graph can introduce you to the Sensus Healthcare team.
Sign up to see every warm intro you have to Sensus Healthcare
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sensus Healthcare team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sensus Healthcare develops Superficial Radiotherapy (SRT) medical devices, including the SRT-100, SRT-100+ and SRT-100 Vision (which adds high-frequency ultrasound imaging), used to treat non-melanoma skin cancer and keloids without surgery. The devices are sold to physicians, institutions and healthcare systems for non-invasive, in-office outpatient treatment.
Founders & leadership
JC
Joseph C. SardanoCo-founder · Chairman & CEOJoseph Sardano is Chief Executive Officer of Sensus Healthcare, a medical device company developing superficial radiotherapy systems for non-melanoma skin cancer and keloid treatment. He has held senior commercialization and operations roles at Xoft (subsidiary of iCAD) and Siemens Healthineers in oncology, and completed management training at McGill University.
KF
Kalman FishmanChief Technology Officer and Chief Operating Officer
AL
Arthur LevineChief Financial Officer2014–2020Arthur Levine brings Big Four and multinational finance experience, including 10+ years internationally, gained through roles at publicly traded and private companies. He has led finance teams and managed capital raising, M&A, IPO processes, and SEC reporting for companies across medical devices, biopharma, fintech, and other sectors.
Board
JH
John HeinrichBoard director
SO
Samuel O'RearBoard director
WM
William McCallBoard director
Reported raises · per SEC filings
Form D private placements$2.2M disclosed across 1 round · 2015
▶$2.2MraisedJan 2016 · 58 investors · Other TechnologyRule 506(b)
▶$2.2MraisedJan 2016 · 58 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- John HeinrichDirector
- Samuel O'RearDirector
- Arthur LevineExecutive Officer
- Joseph C. SardanoExecutive Officer, Director
- William McCallDirector
- Kalman FishmanExecutive Officer
- Offering amount
- $2.2M
- Amount sold
- $2.2M
- Minimum investment
- $25K
- Sales commissions
- $154K
- Placement agents
- Neidiger, Tucker, Bruner, Inc.
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$71.4Mvaluation at IPOJun 2016 · $5.50/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Related companies · 4
American Cancer Society (ACS)The American Cancer Society is a nonprofit organization that provides cancer research updates, screening and prevention guidance, and community engagement opportunities. It serves individuals seeking cancer information and those who want to support cancer research and patient advocacy efforts.
MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
CancerresearchukCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.
MD Anderson Cancer CenterUT MD Anderson is a cancer research and treatment center that provides patient care, conducts research, and offers education in cancer prevention and treatment. It is part of the University of Texas System and operates as a nonprofit medical institution.
Companies working in the same space as Sensus Healthcare.
Frequently asked questions
- What does Sensus Healthcare do?
- Sensus Healthcare develops Superficial Radiotherapy (SRT) medical devices, including the SRT-100, SRT-100+ and SRT-100 Vision (which adds high-frequency ultrasound imaging), used to treat non-melanoma skin cancer and keloids without surgery. The devices are sold to physicians, institutions and healthcare systems for non-invasive, in-office outpatient treatment.
- Who founded Sensus Healthcare?
- Sensus Healthcare was founded by Joseph C. Sardano, Kalman Fishman.
- How much funding has Sensus Healthcare raised?
- Sensus Healthcare has disclosed $2.2M raised across 1 round.
- Where is Sensus Healthcare headquartered?
- Sensus Healthcare is headquartered in Boca Raton, US.